Antifungal susceptibility of Candida species isolated from candiduria

Jundishapur Journal of Microbiology

Volumn 6, Issue 1, 2013, Pages 24-28

  Mahmoudabadi, Ali Zarei ^a   Zarrin, Majid ^a   Fard, Maryam Beheshti ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antifungal agents; Candida species; Candiduria; Susceptibility

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ECONAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDURIA; DISK DIFFUSION; FUNGUS CULTURE; FUNGUS ISOLATION; GEOTRICHUM; HOSPITAL PATIENT; IN VITRO STUDY; IRAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; SPECIES IDENTIFICATION; URINALYSIS; YEAST;

EID: 84870199491     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.4633     Document Type: Article

References (20)

1. Bukhary ZA. Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transpl. 2008;19(3):350-360.
2. Nayman Alpat S, Ozgunes I, Ertem OT, Erben N, Doyuk Kartal E, Tozun M, et al. [Evaluation of risk factors in patients with candiduria]. Mikrobiyol Bul. 2011;45(2):318-324.
3. Kobayashi CC, de Fernandes OF, Miranda KC, de Sousa ED, Silva Mdo R. Candiduria in hospital patients: a study prospective. Mycopathologia. 2004;158(1):49-52.
4. Manzano-Gayosso P, Hernandez-Hernandez F, Zavala-Velasquez N, Mendez-Tovar LJ, Naquid-Narvaez JM, Torres-Rodriguez JM, et al. [Candiduria in type 2 diabetes mellitus patients and its clinical significance. Candida spp. antifungal susceptibility]. Rev Med Inst Mex Seguro Soc. 2008;46(6):603-610.
5. Sellami A, Sellami H, Makni F, Bahloul M, Cheikh-Rouhou F, Bouaziz M, et al. [Candiduria in intensive care unit: significance and value of yeast numeration in urine]. Ann Fr Anesth Reanim. 2006;25(6):584-588.
6. Weinberger M, Sweet S, Leibovici L, Pitlik SD, Samra Z. Correlation between candiduria and departmental antibiotic use. J Hosp Infect. 2003;53(3):183-186.
7. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253-273.
8. Nucci M. Candiduria in hospitalized patients: a review. Braz J Infect Dis. 2000;4(4):168-172.
9. Dalen DM, Zvonar RK, Jessamine PG. An evaluation of the management of asymptomatic catheter-associated bacteriuria and candiduria at The Ottawa Hospital. Can J Infect Dis Med Microbiol. 2005;16(3):166-170.
10. Carvalho M, Guimaraes CM, Mayer JR, Jr., Bordignon GP, Queiroz-Telles F. Hospital-associated funguria: analysis of risk factors, clinical presentation and outcome. Braz J Infect Dis. 2001;5(6):313-318.
11. Fisher JF, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infections--treatment. Clin Infect Dis. 2011;52 Suppl 6:S457-S466.
12. Yang YL, Cheng MF, Chang YW, Young TG, Chi H, Lee SC, et al. Host factors do not influence the colonization or infection by fluconazole resistant Candida species in hospitalized patients. J Negat Results Biomed. 2008;7:12.
13. Cheng MF, Yu KW, Tang RB, Fan YH, Yang YL, Hsieh KS, et al. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis. 2004;48(1):33-37.
14. Yang YL, Cheng HH, Ho YA, Hsiao CF, Lo HJ. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect. 2003;36(3):187-191.
15. Pakshir K, Bahaedinie L, Rezaei Z, Sodaifi M, Zomorodian K. In vitro activity of six antifungal drugs against clinically important dermatophytes. Jundishapur J Microbiol. 2011;2(4):158-163.
16. Pfaller MA, Diekema DJ, Colombo AL, Kibbler C, Ng KP, Gibbs DL, et al. Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the artemis disk antifungal surveillance program. J Clin Microbiol. 2006;44(10):3578-3582.
17. Laverdiere M, Labbe AC, Restieri C, Rotstein C, Heyland D, Madger S, et al. Susceptibility patterns of Candida species recovered from Canadian intensive care units. J Crit Care. 2007;22(3):245-250.
18. Ozcelik B, Kaynak F, Cesur S, Sipahi B, Sultan N. In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens. Jpn J Infect Dis. 2007;60(5):302-304.
19. Al-Abeid HM, Abu-Elteen KH, Elkarmi AZ, Hamad MA. Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants, and antifungal sensitivity. Jpn J Infect Dis. 2004;57(6):279-284.
20. Quindos G, Abarca L, Carrillo-Munoz AJ, Arevalo MP, Bornay FJ, Casals JB, et al. Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients. Rev Iberoam Micol. 1999;16(2):97-100.